Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 2/20 | 0.56 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.56 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.49 |
| ▸ | CA12 | O43570 | 1/20 | 0.47 |
| ▸ | CA1 | P00915 | 1/20 | 0.47 |
| ▸ | CA2 | P00918 | 1/20 | 0.47 |
| ▸ | CA7 | P43166 | 1/20 | 0.47 |
| ▸ | CA9 | Q16790 | 1/20 | 0.47 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.47 |
| ▸ | MMP2 | P08253 | 1/20 | 0.46 |
| ▸ | MMP9 | P14780 | 1/20 | 0.46 |
| ▸ | MMP13 | P45452 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | PDCD1 | Q15116 | 1/20 | 0.43 |
| ▸ | CD274 | Q9NZQ7 | 1/20 | 0.43 |
| ▸ | MIF | P14174 | 3/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | HTR1A | P08908 | 1/20 | 0.42 |
| ▸ | THPO | P40225 | 1/20 | 0.42 |
| ▸ | BLM | P54132 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3012929 | 1.00 | ESR1 (0.56) | ESR1ESR2HIF1ACA12CA1 | |
| SCHEMBL3226833 | 1.00 | ESR1 (0.56) | ESR1ESR2HIF1ACA12CA1 | |
| Ammonia Solution, Strong SCHEMBL7529377 | 0.98 | ESR1 (0.54) | ESR1ESR2HIF1ACA12CA1 | |
| SCHEMBL9000849 | 0.83 | L3MBTL1 (0.47) | ESR1ESR2HIF1AKMT2AALDH1A1 | |
| SCHEMBL8594247 | 0.83 | TDP1 (0.47) | ESR1ESR2KMT2AALDH1A1TDP1 | |
| SCHEMBL8594253 | 0.83 | TDP1 (0.47) | ESR1ESR2KMT2AALDH1A1TDP1 | |
| SCHEMBL9000860 | 0.83 | L3MBTL1 (0.47) | ESR1ESR2HIF1AKMT2AALDH1A1 | |
| SCHEMBL1564925 | 0.82 | CYP1A2 (0.50) | KMT2AALDH1A1SMN1; SMN2KDM4E | |
| SCHEMBL1566235 | 0.82 | HDAC3 (0.46) | CA12CA7CA9CA14KMT2A | |
| SCHEMBL8592635 | 0.82 | SLC6A3 (0.47) | ESR1ESR2KMT2AALDH1A1BLM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-62263087-A | — | — | None | — | — | JP | disclosed |
| US-20260034186-A1 | ENRICHED MINERAL PITCH RESIN PRODUCTS AND METHODS OF MANUFACTURING ENRICHED MINERAL PITCH RESIN PRODUCTS | RIZUN NODARI (US) | 2026-02-05 | — | — | US | disclosed |
| US-20260027136-A1 | CANNABIS BASED THERAPEUTIC AND METHOD OF USE | YUZU LV LLC (US) | 2026-01-29 | — | — | US | disclosed |
| US-12458653-B2 | Cannabis based therapeutic and method of use | YUZU LV LLC (US) | 2025-11-04 | — | — | US | disclosed |
| US-12427176-B2 | Enriched mineral pitch resin products and methods of manufacturing enriched mineral pitch resin products | RIZUN NODARI (US) | 2025-09-30 | — | — | US | disclosed |
| US-12303488-B2 | Cannabis based therapeutic and method of use | YUZU LV LLC (US) | 2025-05-20 | — | — | US | disclosed |
| EP-4417252-A2 | CANNABIS BASED THERAPEUTIC AND METHOD OF USE | Yuzu LV LLC (US) | 2024-08-21 | — | — | EP | disclosed |
| US-20240216457-A1 | ENRICHED MINERAL PITCH RESIN PRODUCTS AND METHODS OF MANUFACTURING ENRICHED MINERAL PITCH RESIN PRODUCTS | RIZUN NODARI (US) | 2024-07-04 | — | — | US | disclosed |
| US-20240216456-A1 | ENRICHED MINERAL PITCH RESIN PRODUCTS AND METHODS OF MANUFACTURING ENRICHED MINERAL PITCH RESIN PRODUCTS | RIZUN NODARI (US) | 2024-07-04 | — | — | US | disclosed |
| US-20240207342-A1 | ENRICHED MINERAL PITCH RESIN PRODUCTS AND METHODS OF MANUFACTURING ENRICHED MINERAL PITCH RESIN PRODUCTS | RIZUN NODARI (US) | 2024-06-27 | — | — | US | disclosed |
| US-20210023044-A1 | CANNABIS BASED THERAPEUTIC AND METHOD OF USE | YUZU LV LLC | 2021-01-28 | — | — | US | disclosed |
| EP-2077987-B1 | MANDELIC ACID DERIVATIVES AND PREPARATION THEREOF | TRANSTECH PHARMA INC (US) | 2010-11-24 | — | — | EP | disclosed |
| US-20100036150-A1 | MANDELIC ACID DERIVATIVES AND PREPARATION THEREOF | TRANSTECH PHARMA, INC. | 2010-02-11 | — | — | US | disclosed |
| US-20100036150-A1 | MANDELIC ACID DERIVATIVES AND PREPARATION THEREOF | TRANSTECH PHARMA, INC. | 2010-02-11 | — | — | US | disclosed |
| US-20100036150-A1 | MANDELIC ACID DERIVATIVES AND PREPARATION THEREOF | TRANSTECH PHARMA, INC. | 2010-02-11 | — | — | US | disclosed |
| EP-2077987-A1 | MANDELIC ACID DERIVATIVES AND PREPARATION THEREOF | Transtech Pharma, Inc. (US) | 2009-07-15 | — | — | EP | disclosed |
| WO-2008051563-A1 | MANDELIC ACID DERIVATIVES AND PREPARATION THEREOF | TRANSTECH PHARMA, INC. (US) | 2008-05-02 | — | — | WO | disclosed |
| WO-2008051563-A1 | MANDELIC ACID DERIVATIVES AND PREPARATION THEREOF | TRANSTECH PHARMA, INC. (US) | 2008-05-02 | — | — | WO | disclosed |
| EP-0816316-A1 | PROCESS FOR PRODUCING 1,2-ETHANEDIOL DERIVATIVES | NITTO CHEMICAL INDUSTRY CO., LTD. (JP) | 1998-01-07 | — | — | EP | disclosed |
| JP-S62263087-A | THERMAL RECORDING MATERIAL | NIPPON SYNTHETIC CHEM IND CO LTD:THE | 1987-11-16 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260027136-A1 | CANNABIS BASED THERAPEUTIC AND METHOD OF USE | CNR1, CNR2, OPRM1 | ESR1 3160/4885ESR2 2308/4885HIF1A 1370/4885 |
| US-20260034186-A1 | ENRICHED MINERAL PITCH RESIN PRODUCTS AND METHODS OF MANUFACTURING ENRICHED MINERAL PITCH RESIN PRODUCTS | TRPV1, SOST, RUNX1 | ESR1 1617/4885ESR2 1839/4885HIF1A 850/4885 |
| US-20100036150-A1 | MANDELIC ACID DERIVATIVES AND PREPARATION THEREOF | CYP8B1, CYP51A1, COMT | ESR1 1977/4885ESR2 3266/4885HIF1A 684/4885 |
| US-20210023044-A1 | CANNABIS BASED THERAPEUTIC AND METHOD OF USE | CNR2, CNR1, OPRK1 | ESR1 3529/4885ESR2 3269/4885HIF1A 1641/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.